Meirav Chovav

Nessuna posizione attualmente

Finance

Profilo

Ms. Chovav is a managing director in the healthcare group of UBS Investment Research.
Analyst since 1992, she specializes in coverage of the biotechnology sector.
Ms. Chovav has ranked on the Institutional Investor All-America Research Team in each of the past eight years, and was ranked a runner-up in the biotechnology category in the 2002 Survey.
She was also recognized as the best stock picker in the biotechnology sector by The Wall Street Journal "Best on the Street" Survey.
Prior to joining UBS, Ms. Chovav was the senior biotechnology analyst at Credit Suisse First Boston and prior to that at Smith Barney.
Ms. Chovav holds an MBA from Rensselaer Polytechnic Institute and an MS in molecular biology from the University of Rochester.

Precedenti posizioni note di Meirav Chovav

Società	Posizione	Fine
UBS Securities LLC UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients.	Analyst-Equity	04/05/2004

Vedi nel dettaglio l'esperienza di Meirav Chovav

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private